questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Molécules d'interaction stromale
Molécules d'interaction stromale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Surveys and Questionnaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Molécules d'interaction stromale : Questions médicales les plus fréquentes",
"headline": "Molécules d'interaction stromale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Molécules d'interaction stromale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-08",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Molécules d'interaction stromale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines membranaires",
"url": "https://questionsmedicales.fr/mesh/D008565",
"about": {
"@type": "MedicalCondition",
"name": "Protéines membranaires",
"code": {
"@type": "MedicalCode",
"code": "D008565",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Molécule-1 d'interaction stromale",
"alternateName": "Stromal Interaction Molecule 1",
"url": "https://questionsmedicales.fr/mesh/D000071737",
"about": {
"@type": "MedicalCondition",
"name": "Molécule-1 d'interaction stromale",
"code": {
"@type": "MedicalCode",
"code": "D000071737",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.875.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Molécule-2 d'interaction stromale",
"alternateName": "Stromal Interaction Molecule 2",
"url": "https://questionsmedicales.fr/mesh/D000071738",
"about": {
"@type": "MedicalCondition",
"name": "Molécule-2 d'interaction stromale",
"code": {
"@type": "MedicalCode",
"code": "D000071738",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.875.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Molécules d'interaction stromale",
"alternateName": "Stromal Interaction Molecules",
"code": {
"@type": "MedicalCode",
"code": "D000071736",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peter B Stathopulos",
"url": "https://questionsmedicales.fr/author/Peter%20B%20Stathopulos",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, London, ON, N6A 5C1, Canada. Electronic address: pstatho@uwo.ca."
}
},
{
"@type": "Person",
"name": "Paul Sohn",
"url": "https://questionsmedicales.fr/author/Paul%20Sohn",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, Indianapolis, IN."
}
},
{
"@type": "Person",
"name": "Wenting Wu",
"url": "https://questionsmedicales.fr/author/Wenting%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN."
}
},
{
"@type": "Person",
"name": "Marjan Slak Rupnik",
"url": "https://questionsmedicales.fr/author/Marjan%20Slak%20Rupnik",
"affiliation": {
"@type": "Organization",
"name": "Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria."
}
},
{
"@type": "Person",
"name": "Chih-Chun Lee",
"url": "https://questionsmedicales.fr/author/Chih-Chun%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Questionnaire survey of geriatricians and primary care physicians' approaches to treating older patients with multimorbidity.",
"datePublished": "2023-07-11",
"url": "https://questionsmedicales.fr/article/37433747",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ggi.14638"
}
},
{
"@type": "ScholarlyArticle",
"name": "Researchers support preprints and open access publishing, but with reservations: A questionnaire survey of MBSJ members.",
"datePublished": "2023-03-06",
"url": "https://questionsmedicales.fr/article/36876468",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/gtc.13015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of functional impairments and discomfort with bonded labial and lingual orthodontic appliances - a questionnaire survey.",
"datePublished": "2024-10-24",
"url": "https://questionsmedicales.fr/article/39449038",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12903-024-05041-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early clinical exposure in undergraduate medical education: A questionnaire survey of 30 European countries.",
"datePublished": "2022-10-31",
"url": "https://questionsmedicales.fr/article/36315584",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0142159X.2022.2137014"
}
},
{
"@type": "ScholarlyArticle",
"name": "Incidence of Leber hereditary optic neuropathy in 2019 in Japan: a second nationwide questionnaire survey.",
"datePublished": "2022-08-20",
"url": "https://questionsmedicales.fr/article/35987635",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13023-022-02478-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Molécules d'interaction stromale",
"item": "https://questionsmedicales.fr/mesh/D000071736"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Molécules d'interaction stromale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Molécules d'interaction stromale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Molécules d'interaction stromale",
"description": "Comment diagnostiquer une interaction stromale ?\nQuels tests sont utilisés pour les molécules stromales ?\nLes marqueurs stromaux sont-ils spécifiques ?\nPeut-on détecter les molécules stromales par imagerie ?\nQuel rôle joue la biopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Surveys+and+Questionnaires&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Molécules d'interaction stromale",
"description": "Quels symptômes sont liés aux interactions stromales ?\nLes interactions stromales causent-elles des symptômes ?\nComment les symptômes varient-ils selon les tumeurs ?\nLes symptômes sont-ils précoces ou tardifs ?\nLes symptômes sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Surveys+and+Questionnaires&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Molécules d'interaction stromale",
"description": "Peut-on prévenir les interactions stromales ?\nQuels modes de vie aident à prévenir les tumeurs ?\nLes dépistages réguliers sont-ils utiles ?\nL'éducation sur le cancer est-elle importante ?\nLes vaccins peuvent-ils prévenir les tumeurs ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Surveys+and+Questionnaires&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Molécules d'interaction stromale",
"description": "Quels traitements ciblent les molécules stromales ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires des traitements ?\nComment les traitements sont-ils personnalisés ?\nLes traitements sont-ils combinés ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Surveys+and+Questionnaires&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Molécules d'interaction stromale",
"description": "Quelles complications peuvent survenir ?\nLes interactions stromales aggravent-elles les complications ?\nComment gérer les complications ?\nLes complications sont-elles prévisibles ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Surveys+and+Questionnaires&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Molécules d'interaction stromale",
"description": "Quels sont les facteurs de risque des interactions stromales ?\nL'alimentation influence-t-elle les risques ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'exposition à des toxines est-elle un risque ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Surveys+and+Questionnaires&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une interaction stromale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des biopsies et des analyses immunohistochimiques sont utilisées pour évaluer les interactions stromales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les molécules stromales ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et les western blots permettent de quantifier les molécules d'interaction stromale."
}
},
{
"@type": "Question",
"name": "Les marqueurs stromaux sont-ils spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains marqueurs peuvent être spécifiques à des types de tumeurs, mais d'autres sont plus généraux."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les molécules stromales par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques d'imagerie avancées, comme l'IRM, peuvent aider à visualiser les interactions stromales."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet d'obtenir des échantillons pour analyser les interactions stromales au sein des tumeurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux interactions stromales ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure douleur, inflammation et signes de progression tumorale."
}
},
{
"@type": "Question",
"name": "Les interactions stromales causent-elles des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent influencer la croissance tumorale et provoquer des symptômes associés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les tumeurs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes dépendent du type de tumeur et de l'environnement stromal spécifique."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils précoces ou tardifs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent être précoces ou tardifs, selon la nature de l'interaction stromale."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent s'améliorer avec un traitement ciblant les interactions stromales."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les interactions stromales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la réduction des facteurs de risque liés aux tumeurs et à l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels modes de vie aident à prévenir les tumeurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les dépistages peuvent aider à détecter les tumeurs précocement, limitant les interactions stromales."
}
},
{
"@type": "Question",
"name": "L'éducation sur le cancer est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation aide à sensibiliser aux facteurs de risque et aux signes précoces de cancer."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir les tumeurs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vaccins, comme ceux contre le HPV, peuvent réduire le risque de cancers associés."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les molécules stromales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des immunothérapies sont en développement pour cibler ces molécules."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité varie selon le type de tumeur et la nature des interactions stromales."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des effets secondaires, notamment des réactions immunitaires."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont adaptés en fonction du profil moléculaire de la tumeur et de l'environnement stromal."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils combinés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des combinaisons de traitements sont souvent utilisées pour améliorer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la progression tumorale, la résistance au traitement et la métastase."
}
},
{
"@type": "Question",
"name": "Les interactions stromales aggravent-elles les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent favoriser la progression tumorale et compliquer le traitement."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique des traitements ciblés et un suivi régulier pour adapter les thérapies."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être anticipées en fonction du type de tumeur et des interactions."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des interactions stromales ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'inflammation chronique, le tabagisme et des prédispositions génétiques."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les risques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut réduire les risques d'interactions stromales."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut influencer l'inflammation et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer peuvent augmenter le risque d'interactions stromales."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des substances toxiques peut favoriser les interactions stromales et le cancer."
}
}
]
}
]
}
Geriatricians and primary care physicians in Japan are expected to provide care to older patients with multimorbidity....
A questionnaire survey was carried out to understand the current approaches to older patients with multimorbidity. A total of 3300 participants, including 1650 geriatric specialists (G) and 1650 prima...
We obtained responses from 439 and 397 specialists in the G and PC, respectively (response rates 26.6 and 24.1%). The overall scores for "diseases" and "backgrounds" were significantly higher in the G...
Geriatricians and primary care physicians have many similarities and differences in their approaches to multimorbidity management. Therefore, there is an urgent need to establish a system in which the...
Since the 1990s, journals have become increasingly online and open access. In fact, about 50% of articles published in 2021 were open access. The use of preprints (i.e., non-peer-reviewed articles) ha...
To compare the levels of functional impairments, discomfort and satisfaction experienced by those treated with full-mouth customized lingual appliances (Lingual appliances), full-mouth self-ligating b...
Patients within one year of the end of treatment were included in the survey and given a questionnaire concerning different kinds of discomfort and difficulties during the treatment process. The quest...
A total of 115 patients participated in the study. In terms of functional impairments and discomfort, the rate and degree of speech difficulty was significantly higher in the Lingual appliances Group ...
Lingual and labial appliances caused similar level of overall pain. Taking into account the overall comfortability, aesthetics and cost, the mixed appliances may be suitable for some patients who have...
Fifteen years ago, a European survey demonstrated widespread adoption of early clinical exposure (ECE) programmes but little emphasis in the curricula of medical schools. We now repeat the survey in l...
Online cross-sectional survey in European medical schools conducted by the EURACT Basic Medical Education Committee in 2021. Descriptive quantitative analyses and a thematic analysis approach were use...
Eighy-nine (48%) medical schools in 30 European countries responded. ECE was used in 65 (73%) of the medical schools, and 88% of ECE programmes took place in primary care. The median total time spent ...
Compared to the previous survey, there was no significant change in the adoption or curricular emphasis of ECE programmes. Institutional attitudes towards certain disciplines and a lack of willingness...
Leber hereditary optic neuropathy (LHON) is an acute or subacute optic neuropathy that mainly affects young males. The first nationwide epidemiological survey of LHON was conducted in 2014 in Japan, a...
A questionnaire was sent to 997 facilities accredited by the Japanese Ophthalmological Society and/or affiliated with the councilors of the Japanese Neuro-Ophthalmology Society. Responses were receive...
The incidence of LHON in 2019 was lower than the estimate in 2014, whereas its prevalence may be similar to that reported in other countries. The accurate estimation of the incidence and prevalence of...
The purpose of this study was to evaluate the effectiveness of a hands-on seminar using a Web conferencing system, based on the post-event questionnaires of the face-to-face and online seminars of the...
This study conducted a national questionnaire survey of Japanese urologists from a treatment perspective for older patients with prostate cancer....
A questionnaire was distributed to 922 teaching hospitals of the Japanese Urological Association. Questionnaire items included years of urologist experience, gender, workplace, treatment equipment own...
In total, 1732 questionnaires were analyzed, with responses evenly distributed across all age groups. Workplaces included general hospitals (49.4%), university hospitals (40.3%), and cancer centers (4...
Less than 15% of urologists used geriatric assessments. Several responded that they would set age limits for highly invasive radical and systemic therapies....
(1) Background: Infection control should be one of the main objectives in the comprehensive medical approach. (2) Methods: A cross-sectional study was conducted from June-July 2022. A questionnaire in...
To investigate the level of statistical support available to UK radiology trainees, and to gather opinions regarding how support may affect their current and future research aspirations....
An online survey was developed, piloted, and distributed to radiology trainees via the UK Radiology Academic Network for Trainees and training programme directors. Research experience, research aspira...
Seventy-nine responses were received, only two (3%) of whom had allocated time for research. Only three (4%) respondents were content with their statistical support whereas 25 (32%) reported insuffici...
Training schemes must improve the provision, access to, and awareness of statistical support so that any research efforts are performed to a high standard. Trainees should not be expected to participa...
Management of hypothyroidism is controversial because of medication cost pressures and scientific uncertainty on how to address treatment dissatisfaction experienced by some patients. The objective wa...
Web-based survey....
UK endocrinologists were invited to participate....
Responses to questionnaire....
The response rate was 21% (272/1295). While levothyroxine monotherapy is regarded as the treatment of choice for hypothyroidism, 51% of respondents stated that combined treatment with levothyroxine an...
UK endocrine practice in management of hypothyroidism is broadly in line with international guidance. However, a minority of respondents would consider thyroid hormone supplementation in euthyroid ind...